Skip to content
Search

Latest Stories

Henry Gregg named as new NPA chief executive

Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.


“I am excited to be joining the NPA at a pivotal time for community pharmacy. I’m looking forward to working with the NPA team, building strong links with government so we can deliver the support pharmacies so desperately need and the bigger role they can undoubtedly play in everyone’s health,” said Gregg.

“I want to focus on fighting for pharmacies and raising the profile of their amazing work, but also making sure the NPA is offering the best possible service and support for a network upon which so many people rely. I can’t wait to meet the team and start meeting NPA members across the UK.”

At Asthma + Lung UK, Gregg has led the campaign to ban cigarettes for everyone born after 2009 and smoking outside hospitals, playgrounds and schools, and also pushed for respiratory vaccines and management of lung conditions in community pharmacies.

Having started his career working in parliament, Gregg went on to gain a wealth of communications, policy and public experience at the Health Foundation and the London Boroughs of Newham and Barking and Dagenham.

He also led member relations at the National Housing Federation, where he supported the housing sector in the aftermath of the Grenfell Tower fire.

Nick Kaye, NPA chair, said: “On behalf of the NPA board I am so delighted to be welcoming Henry to join the NPA as its next chief executive.

“At a time of huge change and enormous opportunity for the community pharmacy network, we are fortunate to have someone with Henry’s experience and insight to lead the organisation as we respond to the challenges ahead.

“The NPA has made tremendous strides over the past months and has given community pharmacy a greater profile than ever before. I’m sure Henry will build on that work to modernise the NPA and ensure we are the strongest possible advocate and servant for the thousands of NPA member pharmacies that are a central part of the health service for millions of people.”

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less
Three pharmacists named in NIHR’s latest cohort of senior investigators

L-R: Professor David Alldred; Professor Rachel Elliott and Professor Ian Maidment.

Three pharmacists appointed as NIHR senior investigators

The National Institute for Health and Care Research (NIHR) has announced its latest cohort of senior investigators, including three distinguished pharmacists.

David Alldred, professor of medicines use and safety at the University of Leeds; Rachel Elliott, professor of health economics at the University of Manchester; and Ian Maidment, professor in clinical pharmacy at Aston University, have been named in the list of 39 new appointments, alongside 19 reappointed senior investigators.

Keep ReadingShow less